Ozcan E, Gokmen I, Akgul F, Kahvecioglu FA, et al. Clinical Outcomes of CDK4/6 Inhibitor Therapy in HR+/HER2- Metastatic Breast Cancer: A Multicenter Comparison of HER2-Low and HER2-Zero Subgroups. Breast J 2025;2025:5577345.
PMID: 40620732